These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 8884161)

  • 21. Clinical use of calcium antagonists in hypertension: update 1986.
    Lund-Johansen P
    J Cardiovasc Pharmacol; 1987; 10 Suppl 10():S29-35. PubMed ID: 2455135
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Major differences among the three classes of calcium antagonists.
    Ferrari R
    Eur Heart J; 1997 Jan; 18 Suppl A():A56-70. PubMed ID: 9049540
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High blood pressure and calcium antagonism.
    Palma-Gámiz JL
    Cardiology; 1997; 88 Suppl 1():39-46. PubMed ID: 9118167
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Calcium antagonists during and after myocardial infarction.
    Sleight P
    Drugs; 1996 Feb; 51(2):216-25. PubMed ID: 8808164
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nifedipine. Dose-related increase in mortality in patients with coronary heart disease.
    Furberg CD; Psaty BM; Meyer JV
    Circulation; 1995 Sep; 92(5):1326-31. PubMed ID: 7648682
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nisoldipine. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the treatment of angina pectoris, hypertension and related cardiovascular disorders.
    Friedel HA; Sorkin EM
    Drugs; 1988 Dec; 36(6):682-731. PubMed ID: 3065058
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lercanidipine : a review of its efficacy in the management of hypertension.
    Bang LM; Chapman TM; Goa KL
    Drugs; 2003; 63(22):2449-72. PubMed ID: 14609358
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Calcium channel blockers. Is it time to split the lump?
    Materson BJ
    Am J Hypertens; 1995 Mar; 8(3):325-9. PubMed ID: 7794584
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Calcium antagonists. Mechanisms, therapeutic indications and reservations: a review.
    Opie LH
    Q J Med; 1984; 53(209):1-16. PubMed ID: 6324268
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treating coexisting cardiovascular and pulmonary disease with calcium antagonists.
    Berman BA; Ross RN
    Ann Allergy; 1986 Mar; 56(3):195-200. PubMed ID: 2420238
    [No Abstract]   [Full Text] [Related]  

  • 31. Mibefradil. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the management of hypertension and angina pectoris.
    Brogden RN; Markham A
    Drugs; 1997 Nov; 54(5):774-93. PubMed ID: 9360062
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Calcium channel blockers in the dock: innocent or guilty?
    Mackay JA; Sever PS
    J Hum Hypertens; 1996 May; 10(5):277-80. PubMed ID: 8817399
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Calcium antagonists in arterial hypertension].
    Muiesan G
    G Ital Cardiol; 1988 Nov; 18(11):982-8. PubMed ID: 3073993
    [No Abstract]   [Full Text] [Related]  

  • 34. 1995: the year of the calcium antagonist controversy.
    Cohen JD
    Curr Opin Nephrol Hypertens; 1996 May; 5(3):214-8. PubMed ID: 8737855
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Calcium channel antagonists. Part IV: Side effects and contraindications drug interactions and combinations.
    Opie LH
    Cardiovasc Drugs Ther; 1988 Jul; 2(2):177-89. PubMed ID: 3154704
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Calcium channel blocking agents. Council on scientific affairs.
    JAMA; 1983 Nov; 250(18):2522-4. PubMed ID: 6685194
    [No Abstract]   [Full Text] [Related]  

  • 37. Safety of calcium antagonists: dissecting the evidence.
    Messerli FH
    Am J Cardiol; 1996 Nov; 78(9A):19-23. PubMed ID: 8903281
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Calcium channel antagonists: morbidity and mortality--what's the evidence?
    Straka RJ; Swanson AL; Parra D
    Am Fam Physician; 1998 Apr; 57(7):1551-60. PubMed ID: 9556644
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Calcium channel blockers: an evidence-based review.
    Waters D
    Can J Cardiol; 1997 Aug; 13(8):757-66. PubMed ID: 9284842
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Safety of calcium antagonists: more ACTION.
    Messerli FH; Staessen JA
    Am J Med; 2005 Dec; 118(12):1418-20. PubMed ID: 16378803
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.